Gene clues may explain lingering blood issues after CAR-T
NCT ID NCT06630104
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times
Summary
This study looks at gene changes that might cause low blood cell counts (cytopenia) in people with multiple myeloma or certain lymphomas after CAR-T therapy. About one-third of patients have low blood counts lasting more than 30 days after treatment. Researchers will test blood and bone marrow samples from 82 participants to find gene mutations linked to this side effect. The goal is to better predict who is at risk, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOPROLIFERATIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic Health System in Albert Lea
RECRUITINGAlbert Lea, Minnesota, 56007, United States
Contact Email: •••••@•••••
-
Mayo Clinic Health System-Eau Claire Clinic
RECRUITINGEau Claire, Wisconsin, 54701, United States
Contact Email: •••••@•••••
-
Mayo Clinic Health System-Franciscan Healthcare
RECRUITINGLa Crosse, Wisconsin, 54601, United States
Contact Email: •••••@•••••
-
Mayo Clinic Health System-Mankato
RECRUITINGMankato, Minnesota, 56001, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Arizona
RECRUITINGScottsdale, Arizona, 85259, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Florida
RECRUITINGJacksonville, Florida, 32224-9980, United States
Contact Email: •••••@•••••
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact